CGNX(CGNX)
CGNX
Q3 2026 EPS Estimate
$0.42
Jul 29, 2026 · Reports after close
Revenue Estimate
$292M
FY2026E EPS$1.48
FY2027E EPS$1.78
Analyst Sentiment
Wall St. Consensus
Buy28 analysts·High coverage
63
Score
15 Buy (54%)11 Hold (39%)2 Sell (7%)
Rating Breakdown
Strong Buy
14%
Buy
1450%
Hold
1139%
Sell
27%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$61.00
-15.4%
Consensus
$73.50
+2.0%
Bull
$80.00
+11.0%
12-Month Target Range28 analysts
$61.00$73.50$80.00
Current $72.09Consensus
Current Price
$72.09
Upside to Consensus
$1.41
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+8.79%
EPS+20.15%
FY2028
Rev+9.81%
EPS+14.67%
FY2029
Rev+15.98%
EPS+22.22%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.11B | $1.21B | $1.32B | $1.54B |
| Low | $1.10B | $1.19B | $1.32B | $1.47B |
| High | $1.12B | $1.23B | $1.32B | $1.58B |
| EBITDA Avg | $262M | $285M | $313M | $362M |
| Low | $259M | $280M | $313M | $348M |
| High | $264M | $289M | $313M | $374M |
| EBIT Avg | $232M | $253M | $278M | $322M |
| Low | $230M | $249M | $278M | $309M |
| High | $234M | $257M | $278M | $332M |
| Net Income Avg | $240M | $287M | $346M | $423M |
| Low | $238M | $287M | $308M | $402M |
| High | $272M | $319M | $416M | $440M |
| EPS Avg | $1.48 | $1.78 | $2.05 | $2.50 |
| Low | $1.40 | $1.69 | $1.82 | $2.37 |
| High | $1.60 | $1.89 | $2.46 | $2.60 |
| Analysts (Rev / EPS) | 14 / 12 | 14 / 13 | 9 / 6 | 4 / 4 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $292M | $280M | $265M | $286M | $313M | $315M | $294M | $320M |
| Low | $289M | $275M | $247M | $267M | $292M | $294M | $275M | $299M |
| High | $294M | $287M | $275M | $297M | $325M | $327M | $305M | $333M |
| EBITDA Avg | $69M | $66M | $62M | $67M | $74M | $74M | $69M | $76M |
| Low | $68M | $65M | $58M | $63M | $69M | $69M | $65M | $71M |
| High | $69M | $68M | $65M | $70M | $77M | $77M | $72M | $79M |
| EBIT Avg | $61M | $59M | $55M | $60M | $66M | $66M | $62M | $67M |
| Low | $61M | $58M | $52M | $56M | $61M | $62M | $58M | $63M |
| High | $62M | $60M | $58M | $62M | $68M | $69M | $64M | $70M |
| Net Income Avg | $71M | $62M | $57M | $66M | $82M | $81M | $72M | $79M |
| Low | $65M | $52M | $52M | $61M | $75M | $74M | $66M | $72M |
| High | $75M | $69M | $60M | $70M | $86M | $85M | $76M | $83M |
| EPS Avg | $0.42 | $0.37 | $0.34 | $0.39 | $0.48 | $0.48 | $0.43 | $0.47 |
| Low | $0.39 | $0.31 | $0.31 | $0.36 | $0.44 | $0.44 | $0.39 | $0.43 |
| High | $0.44 | $0.41 | $0.36 | $0.41 | $0.51 | $0.50 | $0.45 | $0.49 |
| Analysts (Rev / EPS) | 10 / 11 | 10 / 11 | 5 / 8 | 5 / 4 | 5 / 4 | 5 / 6 | 4 / 10 | 4 / 5 |